Myocarditis after BNT162b2 Vaccination in Israeli Adolescents [Letter to the Editor - The New England Journal of Medicine (NEJM), March 2022]

Title:

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

 

Authors:

Dror Mevorach, Emilia Anis, Tal Hasin, Michal Bromberg [et al]

 

Published:

The New England Journal of Medicine (NEJM), 10 March 2022

https://www.nejm.org/doi/full/10.1056/NEJMc2116999

[Published as a Letter to the Editor]

 

From the Letter to the Editor:

Using an active nationwide surveillance system administered by the Israeli Ministry of Health, we previously found a higher incidence of myocarditis among persons 16 years of age or older who had received the BNT162b2 vaccine (Pfizer–BioNTech) than among historical controls and unvaccinated persons; the incidence was highest among young male recipients.

COVID-19 in Hospitalized Ethiopian Children: Characteristics and Outcome Profile (medRxiv, 4 november 2020 - a preprint)

Title:

COVID-19 in Hospitalized Ethiopian Children: Characteristics and Outcome Profile

 

Authors:

Tigist W. Leulseged, Ishmael S. Hassen, Endalkachew H. Maru, Wuletaw C. Zewde, Negat W. Chamiso, Mesay G. Edo, Daniel S. Abebe & Muktar Awol Aliy

[All from the Millennium COVID-19 Care Center, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia]

Published:

medRxiv, 4 November 2020

[Keep in mind that this is a preprint and not yet peer reviewed.]

https://www.medrxiv.org/content/10.1101/2020.10.30.20223115v1

From the Abstract:

Background: Considering the number of people affected and the burden to the health care system due to the Coronavirus pandemic, there is still a gap in understanding the disease better leaving a space for new evidence to be filled by researchers. This scarcity of evidence is observed especially among children with the virus. Understanding the disease pattern and its effect among children is vital in providing timely and targeted intervention. 

 

Aim: To assess the characteristics and outcome profile of 115 RT-PCR confirmed children with COVID-19, and to determine the presence of significant difference in disease severity and survival distribution between groups among children admitted to Millennium COVID-19 Care Center in Ethiopia. 

Research Letter (JAMA, 29 April 2020) - Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Title:
Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs

Authors:
Rishi K. Wadhera, Priya Wadhera, Prakriti Gaba, Jose F. Figueroa, Karen E. Joynt Maddox, Robert W. Yeh & Changyu Shen

Published:
JAMA, published online 29 April 2020
Available: file:///C:/Users/User/Downloads/jama_wadhera_2020_ld_200038.pdf

Focus of research letter:
"In the US, New York City has emerged as the epicenter of the coronavirus disease 2019 (COVID-19) outbreak.1 As of April 25, 2020, more than 150 000 cases had been reported, which is approximately 17% of total cases in the US.2,3 New York City is composed of 5 boroughs (the Bronx, Brooklyn, Manhattan, Queens, and Staten Island), each with unique demographic, socioeconomic, and community characteristics.  

Prior analyses have shown health inequities across these boroughs, but whether similar patterns have also emerged amid the COVID-19 pandemic is unknown.4 Understanding the patterns could inform public health and policy strategies to mitigate the ongoing spread of COVID-19, and future approaches to address a possible resurgence of the disease. Therefore, in this study, we aimed to examine population characteristics and hospital bed capacities across the 5 boroughs and evaluate whether differences in the rates of COVID-19 testing, hospitalizations, and deaths have emerged in these communities."